Tumor Markers Part 2

This tumor marker can detect non-Hodgkin’s lymphoma, acute leukemia, and testicular cancer.

this tumor marker is seen in primary or secondary liver cancer; greatest elevation seen in patients with prostate cancer with bone metastases

This tumor marker is found in neuronal tissue and detects neuroblastomas, carcinoid tumors, and pheochromocytoma.

This tumor marker is primarily used to screen, stage, and monior treatment and recurrence of prostate cancer.

This tumor marker detects pituitary tumors or ectopic ACTH producing tumors

This tumor marker is used to detect familial medullary carcinoma of the thyroid (autosomal dominant)

This tumor marker is used to detect gastrinomas, which cause Zollinger-Ellison syndrome

This marker is elevated in trophoblastic diseases (associated with the uterine endometrial lining) and germ cell tumors; can go along with AFP to identify testicular tumors

these two catecholamines are increased in pheochromocytomas (tumors in adrenal medulla)

This catecholamine is increased in neuroblastomas

This tumor marker arises from carcinoid tumors of the GI tract and pancreas

In cancer patients, production of these antigens demonstrates that certain genes are reactivated during malignant cellular transformation.

this is found in hepatocellular and germ cell (non-seminoma) carcinoma LIVER CANCER

this marker is useful for colorectal carcinoma (70%) COLON CANCER

This marker is elevated in 69% of cases of breast cancer; not used to diagnost but most useful in followup of treated breast cancer

This marker is used for the detection of recurrent breast cancer in patients with stage II or stage III disease

This marker is usedful in detecting active breast cancer, but not early breast cancer

This is used as a marker for ovarian cancer, useful in differentiating benign from malignant disease in patients with palpable ovarian masses